• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自发性细菌性腹膜炎患者死亡率的预测模型

Predictive model of mortality in patients with spontaneous bacterial peritonitis.

作者信息

Poca M, Alvarado-Tapias E, Concepción M, Pérez-Cameo C, Cañete N, Gich I, Romero C, Casas M, Román E, Castells L, Vargas V, Carrión J A, Guarner C, Soriano G

机构信息

Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

CIBERehd, Instituto de Salud Carlos III, Barcelona, Spain.

出版信息

Aliment Pharmacol Ther. 2016 Sep;44(6):629-37. doi: 10.1111/apt.13745. Epub 2016 Jul 28.

DOI:10.1111/apt.13745
PMID:27464682
Abstract

BACKGROUND

Hospital mortality in patients with spontaneous bacterial peritonitis (SBP) is high despite albumin treatment, particularly in those with worse liver and/or renal function.

AIM

To determine the independent predictive factors of in-hospital mortality and to create and validate a predictive model of mortality in patients with SBP.

METHODS

We analysed all cirrhotic patients with high-risk SBP (serum urea ≥11 mmol/L and/or serum bilirubin ≥68 μmol/L) between 2001 and 2011. We developed a predictive model of in-hospital mortality and validated this in a different cohort.

RESULTS

We included 118 high-risk SBP episodes treated with antibiotics and albumin. In-hospital mortality was 33/118 (28%). The independent predictive factors of in-hospital mortality at SBP diagnosis were serum urea, blood leucocyte count, Child-Pugh score and mean arterial pressure. A predictive model including these four variables showed a discrimination accuracy (AUC) of 0.850, 95% CI 0.777-0.922. A cut-off point of 0.245 showed a sensitivity of 0.85 and specificity of 0.75. The in-hospital mortality was 28/49 (57.1%) in patients with a model value ≥0.245, and 5/69 (7.2%) in patients with a model value <0.245 (P < 0.001). The validation series included 161 patients with an in-hospital mortality of 40/161 (24.8%), 30/77 (39.0%) in patients with a model value ≥0.245, and 10/84 (11.9%) in those with a model value <0.245 (P < 0.001).

CONCLUSIONS

We developed and validated a predictive model of mortality that includes serum urea, blood leucocyte count, Child-Pugh score and mean arterial pressure in high-risk patients with spontaneous bacterial peritonitis. These findings may help to identify patients who would benefit from additional therapeutic strategies.

摘要

背景

尽管使用白蛋白治疗,但自发性细菌性腹膜炎(SBP)患者的医院死亡率仍然很高,尤其是那些肝功能和/或肾功能较差的患者。

目的

确定住院死亡率的独立预测因素,并建立和验证SBP患者死亡率的预测模型。

方法

我们分析了2001年至2011年间所有患有高危SBP(血清尿素≥11 mmol/L和/或血清胆红素≥68 μmol/L)的肝硬化患者。我们建立了住院死亡率的预测模型,并在另一个队列中进行了验证。

结果

我们纳入了118例接受抗生素和白蛋白治疗的高危SBP发作患者。住院死亡率为33/118(28%)。SBP诊断时住院死亡率的独立预测因素为血清尿素、血白细胞计数、Child-Pugh评分和平均动脉压。包含这四个变量的预测模型显示判别准确性(AUC)为0.850,95%CI为0.777 - 0.922。截断点为0.245时,敏感性为0.85,特异性为0.75。模型值≥0.245的患者住院死亡率为28/49(57.1%),模型值<0.245的患者住院死亡率为5/69(7.2%)(P < 0.001)。验证系列包括161例患者,住院死亡率为40/161(24.8%),模型值≥0.245的患者为30/77(39.0%),模型值<0.245的患者为10/84(11.9%)(P < 0.001)。

结论

我们建立并验证了一个死亡率预测模型,该模型包括血清尿素、血白细胞计数、Child-Pugh评分和平均动脉压,用于高危自发性细菌性腹膜炎患者。这些发现可能有助于识别那些将从额外治疗策略中获益的患者。

相似文献

1
Predictive model of mortality in patients with spontaneous bacterial peritonitis.自发性细菌性腹膜炎患者死亡率的预测模型
Aliment Pharmacol Ther. 2016 Sep;44(6):629-37. doi: 10.1111/apt.13745. Epub 2016 Jul 28.
2
The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis.22/11 风险预测模型:一种经过验证的模型,可预测肝硬化合并自发性细菌性腹膜炎患者 30 天死亡率。
Am J Gastroenterol. 2013 Sep;108(9):1473-9. doi: 10.1038/ajg.2013.204. Epub 2013 Jul 23.
3
Creatinine modified Child-Turcotte-Pugh and integrated model of end-stage liver disease scores as predictors of spontaneous bacterial peritonitis-related in-hospital mortality: Applicable or not.肌酐修正的Child-Turcotte-Pugh评分和终末期肝病积分模型作为自发性细菌性腹膜炎相关住院死亡率预测指标的适用性研究
J Gastroenterol Hepatol. 2015 Jul;30(7):1205-10. doi: 10.1111/jgh.12918.
4
Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.小肠通透性双糖测试对肝硬化患者细菌感染和死亡率的预测价值不佳:一项前瞻性研究。
World J Gastroenterol. 2016 Mar 21;22(11):3275-84. doi: 10.3748/wjg.v22.i11.3275.
5
Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.自发性细菌性腹膜炎首发时的微生物学与耐药性:对治疗及预后的影响
J Gastroenterol Hepatol. 2016 Jun;31(6):1191-5. doi: 10.1111/jgh.13266.
6
Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis.自发性细菌性腹膜炎患者住院死亡率相关的预后因素。
Ann Hepatol. 2012 Nov-Dec;11(6):915-20.
7
Follow-up Creatinine Level Is an Important Predictive Factor of In-hospital Mortality in Cirrhotic Patients with Spontaneous Bacterial Peritonitis.随访肌酐水平是肝硬化合并自发性细菌性腹膜炎患者住院死亡率的重要预测因素。
J Korean Med Sci. 2018 Mar 19;33(12):e99. doi: 10.3346/jkms.2018.33.e99.
8
EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.伴有腹水和自发性细菌性腹膜炎的失代偿期肝硬化预后因素评估
Rev Med Chir Soc Med Nat Iasi. 2015 Oct-Dec;119(4):1018-24.
9
High-sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis.高敏C反应蛋白水平是肝硬化自发性细菌性腹膜炎患者预后不良的独立预测指标。
J Clin Gastroenterol. 2014 May-Jun;48(5):444-9. doi: 10.1097/MCG.0b013e3182a6cdef.
10
Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis.延迟穿刺与自发性细菌性腹膜炎患者的住院死亡率增加有关。
Am J Gastroenterol. 2014 Sep;109(9):1436-42. doi: 10.1038/ajg.2014.212. Epub 2014 Aug 5.

引用本文的文献

1
Predictors of Mortality in Patients with Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎患者死亡的预测因素
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):125-128. doi: 10.5005/jp-journals-10018-1436. Epub 2024 Dec 27.
2
Short and long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients.肝硬化患者自发性细菌性腹膜炎的短期和长期死亡率
Medicine (Baltimore). 2024 Dec 13;103(50):e40851. doi: 10.1097/MD.0000000000040851.
3
Retrospective Investigation of Factors Affecting Mortality in Spontaneous Bacterial Peritonitis.
自发性细菌性腹膜炎死亡率影响因素的回顾性调查
Euroasian J Hepatogastroenterol. 2023 Jan-Jun;13(1):5-9. doi: 10.5005/jp-journals-10018-1387.
4
Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma.肝硬化合并肝细胞癌自发性细菌性腹膜炎的初始治疗反应和短期死亡率。
Sci Rep. 2023 Apr 13;13(1):6067. doi: 10.1038/s41598-023-32006-8.
5
A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis.一种潜在的新型炎症生物标志物,可预测失代偿期肝硬化的预后。
Ann Med. 2022 Dec;54(1):3201-3210. doi: 10.1080/07853890.2022.2142277.
6
Spontaneous bacterial peritonitis: a prospective Greek multicenter study of its epidemiology, microbiology, and outcomes.自发性细菌性腹膜炎:一项关于其流行病学、微生物学及预后的希腊前瞻性多中心研究。
Ann Gastroenterol. 2022 Jan-Feb;35(1):80-87. doi: 10.20524/aog.2021.0674. Epub 2021 Nov 10.
7
Predictors of Short-Term Mortality Following First Episode of Spontaneous Bacterial Peritonitis in Hospitalized Cirrhotic Patients.住院肝硬化患者自发性细菌性腹膜炎首发后的短期死亡率预测因素
Cureus. 2021 Oct 23;13(10):e18999. doi: 10.7759/cureus.18999. eCollection 2021 Oct.
8
Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.首次发生自发性细菌性腹膜炎的肝硬化患者一年生存率预后模型的开发与验证
J Clin Transl Hepatol. 2021 Oct 28;9(5):647-654. doi: 10.14218/JCTH.2021.00031. Epub 2021 May 24.
9
Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.肝硬化患者的自发性细菌性腹膜炎:发病率、转归及治疗策略。
Hepat Med. 2019 Jan 14;11:13-22. doi: 10.2147/HMER.S164250. eCollection 2019.
10
Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.非选择性β受体阻滞剂治疗影响肝硬化患者对细菌 DNA 的全身炎症反应。
Liver Int. 2018 Dec;38(12):2219-2227. doi: 10.1111/liv.13890. Epub 2018 Jun 19.